Skip to content

Assessing Pain and Effectiveness of Carevix Device for IUD Insertions

The Carevix Device: Assessing Pain and Effectiveness of a Suction-based Cervical Stabilizer for IUD Insertions in the Clinic Setting: a Randomized, Controlled Trial (CARE)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07290517
Acronym
CARE
Enrollment
100
Registered
2025-12-18
Start date
2026-03-11
Completion date
2027-03-01
Last updated
2026-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Uterine Bleeding, IUD, Pain, Cervical

Keywords

IUD insertion, Cervical Stabilization, Tenaculum, Pain

Brief summary

The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between IUD insertions using a suction cervical stabilizer (new device, FDA approved, atraumatic) and single-tooth tenaculum (standard, traumatic). Our aims are to: * assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum. * assess predictors of pain scores including between nulliparous and multiparous patients * assess provider-reported ease of use and satisfaction Participants (including providers) will: * be randomized to receive one device to complete the IUD procedure * complete a survey following the procedure

Detailed description

The primary objective is to assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum. The hypothesis is that patient-reported pain scores comparing Carevix™ to tenaculum will be lower. The investigators will assess pain, and predictors for pain scores including nulliparous vs multiparous, when highest pain scores are reported, and expectation of pain for the procedure. The secondary objective will be to assess Usability (provider assessment of ease of use, number of device placement attempts to secure sufficient traction on uterus), efficacy (ability to insert IUD with Carevix™ device alone without recourse to conventional tenaculum or other instruments), provider reported bleeding (cervical bleeding and ecchymosis), overall provider satisfaction, patient-reported pain scores at device placement prior to IUD insertion procedure and after completion of IUD insertion using Visual Analog Scale (VAS), overall patient satisfaction, and overall provider satisfaction. The investigators aim to expand the pilot trial data collection to assess cultural background, ethnicity and demographics while also assessing prior contraceptive choices, reasons for discontinuation of prior choices and reasons for current selection of IUD insertion and any anticipated barriers for removal.

Interventions

DEVICECarevix

Vacuum cervical stabilization device

DEVICETenaculum

Standard of care cervical stabilization device

Sponsors

Indiana University
Lead SponsorOTHER
Aspivix SA
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

Patients will be randomized, but are unable to be blinded.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(to be assessed prior to procedure): * Age 18 years or older * Able to consent on their own * Scheduled and will undergo an IUD insertion within 90 days of consent * Planned use of cervical stabilization device for placement * Procedure being performed by a trained provider * Provider is willing to use Carevix™ for scheduled procedure

Exclusion criteria

(to be assessed by provider at time of procedure): * Vaginal bleeding of unknown origin * Cervix less than 26 mm in diameter * Nabothian cyst on anterior lip of cervix * Cervical myomas * Cervical abnormalities/shape * Pregnant * Participants who are not fluent in and/or do not fully understand, read, write, or speak the English language * Other inability to provide informed consent to participate * Initial attempt to place the IUD without any cervical stabilization

Design outcomes

Primary

MeasureTime frameDescription
Patient pain scoreDuring Procedure (at Cervix Grasping, at Cervix Traction, and at IUD placement)Participants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."
Difference in Pain ScorePrior to procedure, during procedure (at cervix grasping, at cervix traction, at IUD placement), and 5 minutes after procedure completionParticipants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable." Pain scores will be compared among nulliparous and multiparous participants
Highest Pain ScorePrior to procedure, during procedure (at cervix grasping, at cervix traction, at IUD placement), and 5 minutes after procedure completionParticipants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable." The time at which the highest pain score was reported will be compared.
Expectation of PainWithin 15 minutes after IUD procedure completionParticipants will be asked to rate their expectation of pain on a scale of 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."

Secondary

MeasureTime frameDescription
Provider device satisfaction - Time to Use DeviceImmediately after IUD procedureProviders will be asked to provide their agreement that procedure time was not extended due to the device use on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Provider device satisfaction - Impact on Patient DiscomfortImmediately after IUD insertion procedureProviders will be asked whether the device's use impacted patient discomfort on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree."
Provider device satisfaction - Device PreferenceImmediately after IUD insertion procedureProviders will be asked to rate their overall satisfaction with the device on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Provider device satisfaction - Procedure VisibilityImmediately after IUD insertion procedureProviders will be asked to rate visibility while using the device on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Provider device satisfaction - Pulling StrengthImmediately after IUD insertion procedureProviders will be asked to rate the device's pulling strength as adequate on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"
Provider device satisfaction (Ease of Use)Immediately after IUD procedureProviders using the Carevix device will be asked to rate ease of use on a 5 point Likert scale from "Strongly Disagree"-"Strongly Agree."
Number of Device Placement AttemptsImmediately after IUD insertion procedureProviders are asked to report the number of attempts required for device placement
Need for Device ReplacementImmediately after IUD insertion procedureProviders who use the Carevix device will be asked if the procedure's successful completion required replacing the Carevix device with the cervical tenaculum
Provider Reported BleedingImmediately after IUD insertion procedureThe number of providers who had to manage or stop bleeding on cervical tissues will be compared.
Time to Bleeding CessationImmediately after IUD procedure completionThe time (minutes) required for the providers to stop bleeding of cervical tissues will be compared.
Patient pain scorePrior to Procedure and 5 minutes after procedure completionParticipants will be asked to rate their pain prior to, during, and after the IUD insertion procedure on a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."
Overall Patient SatisfactionImmediately after IUD procedure completionParticipants will rate their satisfaction with the procedure on a 5 point Likert scale from 5 point Likert scale from "Strongly Disagree"-"Strongly Agree"

Countries

United States

Contacts

CONTACTAlissa M Conklin, MD
alconkli@iu.edu317-944-8231
CONTACTKylie L Williams, MA
kylowill@iu.edu
PRINCIPAL_INVESTIGATORAlissa M Conklin, MD

Indiana School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026